An update from Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) is now available. Shanghai Henlius Biotech, Inc. announced that its New Drug ...

Researchers from Simon Fraser University have unveiled an artificial intelligence framework that could transform drug ...

The U.S. Food and Drug Administration (FDA) has announced FDA “PreCheck,” a new regulatory program intended to streamline the development and ...

Cognition Therapeutics shares rose 30% pre-market after the FDA confirmed its Phase 3 trial for Alzheimer's drug Zervimesine.

The newly announced program targeting domestic manufacturing is the latest Trump administration move to ramp up drugmaking in ...

Indoco Remedies receives US FDA final approval for rivaroxaban tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg: Our Bureau, Mumbai Wednesday, August 13, 2025, 13:45 Hrs [IST] Indoco R ...

Mumbai: Indoco Remedies Ltd. has received final approval from the US Food and Drug Administration (USFDA) for the Company's ...

In the phase 2 SunRISe-1 trial, TAR-200, a slow-release intravesical device delivering gemcitabine, eliminated tumors in 82% ...

A new FDA program will use a two-phase approach to help boost domestic drug manufacturing, while OpenAI is leaning into health care with the launch of GPT-5.

US FDA grants fast track designation to AAVantgarde Bio’s AAVB-039 to treat Stargardt disease: Milan Thursday, August 14, 2025, 09:00 Hrs [IST] AAVantgarde Bio (AAVantgarde), a ...

Net loss (GAAP) widened year over year for the six months ended Q2 2025, driven by sharply higher research and administrative expenses. Revenue (GAAP) fell 31.0% year-over-year for the six months ...

Researchers at the Optics and Photonics Research Center (CePOF) have succeeded in increasing the susceptibility of the fungus ...